Biogen Idec Inc. (BIIB) was a big mover last session with shares rising over 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the uptrend for the company since Nov 7, as the stock is now up over 23%.
This biotechnology company saw four positive estimate revisions in the last 30 days. Its Zacks Consensus Estimate also moved higher over the same period, implying more solid trading potential for Biogen Idec. So make sure to keep an eye on this stock going forward to see if Friday’s rally can turn into more strength down the road.
Biogen Idec currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
However, some better-ranked stocks in the same sector include Actelion Ltd. (ALIOF), Heska Corporation (HSKA) and Affymetrix Inc. (AFFX). While Actelion and Heska sport a Zacks Rank #1 (Strong Buy), Affymetrix carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment